Epidermolysis bullosa simplex
MONDO:0017610Epidermolysis bullosa simplex (EBS) is a group of hereditary epidermolysis bullosa (HEB) disorders characterized by skin fragility resulting in intraepidermal blisters and erosions that occur either spontaneously or after physical trauma.
Also known as: EBS, EEB, epidermolysis bullosa simplex, epidermolysis bullosa intraepidermic
6 clinical trials for this condition and its sub-types, 5 tagged with Epidermolysis bullosa simplex itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Epidermolysis bullosa simplex
-
3 sub-types
-
New cream aims to soothe butterfly skin in Late-Stage trial
Symptom relief Not yet recruitingThis Phase 3 study tests the safety of SD-101 cream (6% allantoin) in 80 people with epidermolysis bullosa, a condition that causes fragile, blistering skin. Participants must have completed a prior study (SD-007). The main goal is to track any side effects over time.
Phase 3 • Sponsor: Paradigm Therapeutics • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Can a birch bark gel soothe blistering skin disease?
Symptom relief Not yet recruitingThis pilot trial is testing whether a topical gel called Filsuvez, made from birch triterpenes, is safe and helpful for people aged 6 months and older with moderate-to-severe epidermolysis bullosa simplex (EBS), a condition causing fragile skin and blisters. Participants will app…
Phase 2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC